HDL Induces the Expression of the M2 Macrophage Markers Arginase 1 and Fizz-1 in a STAT6-Dependent Process

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Sanson, Marie ^a   Distel, Emilie ^a   Fisher, Edward A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CELL MARKER; CELL PROTEIN; FEDRATINIB; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 4; JANUS KINASE 1; JANUS KINASE 2; PROTEIN FIZZ 1; RUXOLITINIB; STAT3 PROTEIN; STAT6 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARG 1 GENE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; FIZZ 1 GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE REPRESSION; IMMUNOREGULATION; INFLAMMATION; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIMARY CELL CULTURE; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; ARGINASE; BASE SEQUENCE; BIOLOGICAL MARKERS; DNA PRIMERS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-4; LIPOPROTEINS, HDL; MACROPHAGES; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; STAT3 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR;

EID: 84882658553     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074676     Document Type: Article

References (46)

1. Moore KJ, Tabas I, (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145: 341-355. doi:10.1016/j.cell.2011.04.005. PubMed: 21529710.
2. Feig JE, Quick JS, Fisher EA, (2009) The role of a murine transplantation model of atherosclerosis regression in drug discovery. Curr Opin Investig Drugs 10: 232-238. PubMed: 19333880.
3. Reis ED, Li J, Fayad ZA, Rong JX, Hansoty D, et al. (2001) Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J Vasc Surg 34: 541-547. doi:10.1067/mva.2001.115963. PubMed: 11533609.
4. Llodrá J, Angeli V, Liu J, Trogan E, Fisher EA, et al. (2004) Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci U S A 101: 11779-11784. doi:10.1073/pnas.0403259101. PubMed: 15280540.
5. Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, et al. (2011) HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc Natl Acad Sci U S A 108: 7166-7171. doi:10.1073/pnas.1016086108. PubMed: 21482781.
6. Trogan E, Feig JE, Dogan S, Rothblat GH, Angeli V, et al. (2006) Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc Natl Acad Sci U S A 103: 3781-3786. doi:10.1073/pnas.0511043103. PubMed: 16537455.
7. Feig JE, Vengrenyuk Y, Reiser V, Wu C, Statnikov A, et al. (2012) Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome. PLOS ONE 7: e39790. doi:10.1371/journal.pone.0039790. PubMed: 22761902.
8. Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, et al. (2008) High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 28: 2071-2077. doi:10.1161/ATVBAHA.108.168690. PubMed: 18617650.
9. Tang C, Liu Y, Kessler PS, Vaughan AM, Oram JF, (2009) The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J Biol Chem 284: 32336-32343. doi:10.1074/jbc.M109.047472. PubMed: 19783654.
10. Yvan-Charvet L, Welch C, Pagler TA, Ranalletta M, Lamkanfi M, et al. (2008) Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 118: 1837-1847. doi:10.1161/CIRCULATIONAHA.108.793869. PubMed: 18852364.
11. Zhu X, Lee JY, Timmins JM, Brown JM, Boudyguina E, et al. (2008) Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J Biol Chem 283: 22930-22941. doi:10.1074/jbc.M801408200. PubMed: 18552351.
12. Mandal P, Pratt BT, Barnes M, McMullen MR, Nagy LE, (2011) Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin. J Biol Chem 286: 13460-13469. doi:10.1074/jbc.M110.204644. PubMed: 21357416.
13. Hatch FT, (1968) Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6: 1-68. PubMed: 4179999.
14. Shearer JD, Richards JR, Mills CD, Caldwell MD, (1997) Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am J Physiol 272: E181-E190. PubMed: 9124321.
15. Khallou-Laschet J, Varthaman A, Fornasa G, Compain C, Gaston AT, et al. (2010) Macrophage plasticity in experimental atherosclerosis. PLOS ONE 5: e8852. doi:10.1371/journal.pone.0008852. PubMed: 20111605.
16. Thomas AC, Sala-Newby GB, Ismail Y, Johnson JL, Pasterkamp G, et al. (2007) Genomics of foam cells and nonfoamy macrophages from rabbits identifies arginase-I as a differential regulator of nitric oxide production. Arterioscler Thromb Vasc Biol 27: 571-577. doi:10.1161/01.ATV.0000256470.23842.94. PubMed: 17194896.
17. Gray MJ, Poljakovic M, Kepka-Lenhart D, Morris SM Jr., (2005) Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta. Gene 353: 98-106. doi:10.1016/j.gene.2005.04.004. PubMed: 15922518.
18. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, et al. (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19: 4046-4055. doi:10.1093/emboj/19.15.4046. PubMed: 10921885.
19. Liu T, Dhanasekaran SM, Jin H, Hu B, Tomlins SA, et al. (2004) FIZZ1 stimulation of myofibroblast differentiation. Am J Pathol 164: 1315-1326. doi:10.1016/S0002-9440(10)63218-X. PubMed: 15039219.
20. Raes G, Noël W, Beschin A, Brys L, de Baetselier P, et al. (2002) FIZZ1 and Ym as tools to discriminate between differentially activated macrophages. Dev Immunol 9: 151-159. doi:10.1080/1044667031000137629. PubMed: 12892049.
21. Murphy AJ, Akhtari M, Tolani S, Pagler T, Bijl N, et al. (2011) ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Invest 121: 4138-4149. doi:10.1172/JCI57559. PubMed: 21968112.
22. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE, (1999) The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17: 701-738. doi:10.1146/annurev.immunol.17.1.701. PubMed: 10358772.
23. Stütz AM, Pickart LA, Trifilieff A, Baumruker T, Prieschl-Strassmayr E, et al. (2003) The Th2 cell cytokines IL-4 and IL-13 regulate found in inflammatory zone 1/resistin-like molecule alpha gene expression by a STAT6 and CCAAT/enhancer-binding protein-dependent mechanism. J Immunol 170: 1789-1796. PubMed: 12574343.
24. Lu X, Malumbres R, Shields B, Jiang X, Sarosiek KA, et al. (2008) PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling. Blood 112: 4098-4108. doi:10.1182/blood-2008-03-148726. PubMed: 18716132.
25. Frias MA, James RW, Gerber-Wicht C, Lang U, (2009) Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate. Cardiovasc Res 82: 313-323.
26. Murray PJ, (2006) Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 6: 379-386. doi:10.1016/j.coph.2006.01.010. PubMed: 16713356.
27. Rolling C, Treton D, Pellegrini S, Galanaud P, Richard Y, (1996) IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells. FEBS Lett 393: 53-56.
28. Biswas A, Bhattacharya A, Kar S, Das PK, (2011) Expression of IL-10-triggered STAT3-dependent IL-4Ralpha is required for induction of arginase 1 in visceral leishmaniasis. Eur J Immunol 41: 992-1003. doi:10.1002/eji.201040940. PubMed: 21413004.
29. Cortes JR, Perez GM, Rivas MD, Zamorano J, (2007) Kaempferol inhibits IL-4-induced STAT6 activation by specifically targeting JAK3. J Immunol 179: 3881-3887.
30. Wurster AL, Tanaka T, Grusby MJ, (2000) The biology of Stat4 and Stat6. Oncogene 19: 2577-2584. doi:10.1038/sj.onc.1203485. PubMed: 10851056.
31. Choi H, Choi H, Han J, Jin SH, Park JY, et al. (2013) IL-4 inhibits the melanogenesis of normal human melanocytes through the JAK2-STAT6 signaling pathway. J Invest Dermatol 133: 528-536. doi:10.1038/jid.2012.331. PubMed: 22992805.
32. Williams HJ, Fisher EA, Greaves DR, (2012) Macrophage differentiation and function in atherosclerosis: opportunities for therapeutic intervention? J Innate Immun 4: 498-508. doi:10.1159/000336618. PubMed: 22572544.
33. Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, et al. (2007) Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 117: 746-756. doi:10.1172/JCI26206. PubMed: 17332893.
34. Egom EE, Mamas MA, Soran H, (2013) HDL quality or cholesterol cargo: what really matters- spotlight on sphingosine-1-phosphate-rich HDL. Curr Opin Lipidol, 24: 351-6. PubMed: 23652570.
35. Sica A, Mantovani A, (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122: 787-795. doi:10.1172/JCI59643. PubMed: 22378047.
36. Ramana CV, Gil MP, Schreiber RD, Stark GR, (2002) Stat1-dependent and-independent pathways in IFN-gamma-dependent signaling. Trends Immunol 23: 96-101. doi:10.1016/S1471-4906(01)02118-4. PubMed: 11929133.
37. Albasanz-Puig A, Murray J, Namekata M, Wijelath ES, (2012) Opposing roles of STAT-1 and STAT-3 in regulating vascular endothelial growth factor expression in vascular smooth muscle cells. Biochem Biophys Res Commun 428: 179-184. doi:10.1016/j.bbrc.2012.10.037. PubMed: 23068100.
38. Miyamoto H, Katsuyama E, Miyauchi Y, Hoshi H, Miyamoto K, et al. (2012) An essential role for STAT6-STAT1 protein signaling in promoting macrophage cell-cell fusion. J Biol Chem 287: 32479-32484. doi:10.1074/jbc.M112.358226. PubMed: 22865856.
39. Liu Y, Tang C, (2012) Regulation of ABCA1 functions by signaling pathways. Biochim Biophys Acta 1821: 522-529. doi:10.1016/j.bbalip.2011.08.015. PubMed: 21920460.
40. Vaughan AM, Oram JF, (2005) ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins. J Biol Chem 280: 30150-30157. doi:10.1074/jbc.M505368200. PubMed: 15994327.
41. Sehgal PB, Guo GG, Shah M, Kumar V, Patel K, (2002) Cytokine signaling: STATS in plasma membrane rafts. J Biol Chem 277: 12067-12074. doi:10.1074/jbc.M200018200. PubMed: 11815625.
42. Sankaranarayanan S, de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Weibel GL, et al. (2010) Importance of macrophage cholesterol content on the flux of cholesterol mass. J Lipid Res 51: 3243-3249. doi:10.1194/jlr.M008441. PubMed: 20713652.
43. Rader DJ, Tall AR, (2012) The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis? Nat Med 18: 1344-1346. doi:10.1038/nm.2937. PubMed: 22961164.
44. Hewing B, Moore KJ, Fisher EA, (2012) HDL and cardiovascular risk: time to call the plumber? Circ Res 111: 1117-1120. doi:10.1161/CIRCRESAHA.112.280958. PubMed: 23065341.
45. Feig JE, Parathath S, Rong JX, Mick SL, Vengrenyuk Y, et al. (2011) Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation 123: 989-998. doi:10.1161/CIRCULATIONAHA.110.984146. PubMed: 21339485.
46. Cardilo-Reis L, Gruber S, Schreier SM, Drechsler M, Papac-Milicevic N, et al. (2012) Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype. EMBO Mol Med 4: 1072-1086. doi:10.1002/emmm.201201374. PubMed: 23027612.